# Wave Life Sciences (WVE) — News

WVE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/wve/news

## Recent headlines

- [Wave Life Sciences - WVE-006 continues to be generally safe and well tolerated with no liver toxicities](https://www.ainvest.com/news/wave-life-sciences-wve-006-continues-generally-safe-tolerated-liver-toxicities-2610) — AInvest Wire, Oct 1, 2026
- [Wave Life Sciences - Plans two-year registration trial with one-year interim analysis for accelerated approval](https://www.ainvest.com/news/wave-life-sciences-plans-year-registration-trial-year-interim-analysis-accelerated-approval-2610) — AInvest Wire, Oct 1, 2026
- [Wave Life: Eligible for up to $330M-$375M per GSK program](https://www.ainvest.com/news/wave-life-eligible-330m-375m-gsk-program-2609) — AInvest Wire, Sep 30, 2026
  Wave Life Sciences (NASDAQ: WVE) has disclosed potential milestone payments of up to $330 million to $375 million per program under its collaboration with GlaxoSmithKline (GSK). These figures represent the maximum possible payments Wave could receive based on the terms of the partnership, which…
- [Wave Life Sciences: GSK's candidate uses Spina design siRNA](https://www.ainvest.com/news/wave-life-sciences-gsk-candidate-spina-design-sirna-2609) — AInvest Wire, Sep 30, 2026
- [Wave Life Sciences to get $12M GSK milestone payment](https://www.ainvest.com/news/wave-life-sciences-12m-gsk-milestone-payment-2609) — AInvest Wire, Sep 30, 2026
  Wave Life Sciences is set to receive a $12 million milestone payment from GlaxoSmithKline (GSK) as part of their ongoing collaboration in the development of RNA-based therapeutics. The payment is tied to the achievement of specific developmental and regulatory milestones under the terms of their…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).